Peroxisome proliferator-activated receptor-γ ligand reduced tumor necrosis factor-α-induced interleukin-8 production and growth in endometriotic stromal cells
暂无分享,去创建一个
[1] M. Belvisi,et al. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation. , 2006, European journal of pharmacology.
[2] P. Crosignani,et al. Advances in the management of endometriosis: an update for clinicians. , 2006, Human reproduction update.
[3] H. Aytan,et al. Effect of Peroxisome Proliferator—Activated Receptor-γ Agonist Rosiglitazone on the Induction of Endometriosis in an Experimental Rat Model , 2006, The Journal of the Society for Gynecologic Investigation: JSGI.
[4] B. Staels,et al. Therapeutic roles of peroxisome proliferator-activated receptor agonists. , 2005, Diabetes.
[5] Felicitas Genze,et al. Inhibition of IκB Kinase Activity by Acetyl-boswellic Acids Promotes Apoptosis in Androgen-independent PC-3 Prostate Cancer Cells in Vitro and in Vivo* , 2005, Journal of Biological Chemistry.
[6] D. Lebovic,et al. Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis. , 2004, Fertility and sterility.
[7] Robert N. Taylor,et al. Peroxisome proliferator-activated receptor-gamma ligand inhibition of RANTES production by human endometriotic stromal cells is mediated through an upstream promoter element. , 2003, Fertility and sterility.
[8] N. Terakawa,et al. Tumor Necrosis Factor-α-Induced Interleukin-8 (IL-8) Expression in Endometriotic Stromal Cells, Probably through Nuclear Factor-κB Activation: Gonadotropin-Releasing Hormone Agonist Treatment Reduced IL-8 Expression , 2003 .
[9] I. Verma,et al. NF-κB regulation in the immune system , 2002, Nature Reviews Immunology.
[10] Dallas Jones,et al. Emerging roles of PPARS in inflammation and immunity , 2002, Nature Reviews Immunology.
[11] M. Hornstein,et al. Prolonged GnRH Agonist and Add‐Back Therapy for Symptomatic Endometriosis: Long‐term Follow‐up , 2002, Obstetrics and gynecology.
[12] Robert N. Taylor,et al. PPAR-γ Decreases Endometrial Stromal Cell Transcription and Translation of RANTES in Vitro , 2002 .
[13] N. Terakawa,et al. Role of cytokines in endometriosis. , 2001, Fertility and sterility.
[14] Robert N. Taylor,et al. Nuclear Peroxisome Proliferator-Activated Receptors a and g Have Opposing Effects on Monocyte Chemotaxis in Endometriosis , 2000 .
[15] D. Wallwiener,et al. Chemokine bioactivity of RANTES in endometriotic and normal endometrial stromal cells and peritoneal fluid. , 2001, Molecular human reproduction.
[16] S. Kato,et al. Ligand type-specific Interactions of Peroxisome Proliferator-activated Receptor γ with Transcriptional Coactivators* , 2000, The Journal of Biological Chemistry.
[17] Youngmi Kim Pak,et al. Oxidized Low Density Lipoprotein Inhibits Interleukin-12 Production in Lipopolysaccharide-activated Mouse Macrophages via Direct Interactions between Peroxisome Proliferator-activated Receptor-γ and Nuclear Factor-κB* , 2000, The Journal of Biological Chemistry.
[18] N. Terakawa,et al. Tumor Necrosis Factor-α Promotes Proliferation of Endometriotic Stromal Cells by Inducing Interleukin-8 Gene and Protein Expression , 2000 .
[19] M. Lazar,et al. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. , 1999, The Journal of clinical investigation.
[20] N. Terakawa,et al. Pathogenetic significance of increased levels of interleukin-8 in the peritoneal fluid of patients with endometriosis. , 1998, Fertility and sterility.
[21] N. Terakawa,et al. Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis. , 1997, American journal of obstetrics and gynecology.
[22] T. Torgerson,et al. Inhibition of Nuclear Translocation of Transcription Factor NF-κB by a Synthetic Peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence (*) , 1995, The Journal of Biological Chemistry.
[23] J. D. Miller,et al. Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Lupron Study Group. , 1990, Fertility and sterility.
[24] L. Kwei,et al. Efficacy and safety of nafarelin in the treatment of endometriosis. , 1990, American journal of obstetrics and gynecology.